NCT01998607 Survey of XGEVA® Presrcibers in Europe to Evaluate Their Knowledge of the Summary of Product Characteristics Pertaining to Osteonecrosis of the Jaw Status COMPLETED Phase N/A
NCT01997892 TRANSFORM - Observational Cohort Study of Darbepoetin Alfa Use in European Union (EU) Hemodialysis Patients Switched From PEG Epoetin Beta Status COMPLETED Phase N/A
NCT01992159 Efficacy, Safety and Tolerability of Romosozumab in the Treatment of Japanese Women With Postmenopausal Osteoporosis Status COMPLETED Phase PHASE2
NCT01991873 Maintenance Therapy With 5-FU/FA Plus Panitumumab vs. 5-FU/FA Alone After Prior Induction and Re-induction After Progress for 1st-line Treatment of Metastatic Colorectal Cancer Status COMPLETED Phase PHASE2
NCT01988103 Efficacy and Safety Study of Two Doses of Apremilast (CC-10004) In Japanese Patients With Moderate-To-Severe Plaque-Type Psoriasis Status COMPLETED Phase PHASE2
NCT01987232 Phase 1b/2 Study of Carfilzomib, Carboplatin, and Etoposide in Patients With Previously Untreated Extensive Stage Small-cell Lung Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT01984424 Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects-3 Status COMPLETED Phase PHASE3
NCT01980589 A Multicenter, Open-label, Phase 1b Study of Carfilzomib, Cyclophosphamide and Dexamethasone in Newly Diagnosed Multiple Myeloma Subjects Status COMPLETED Phase PHASE1
NCT01971346 The Immunological Basis for Treatment Resistance to Anti-TNF Treatments Status COMPLETED Phase PHASE4
NCT01970488 Study to Compare Efficacy and Safety of ABP 501 and Adalimumab (HUMIRA®) in Adults With Moderate to Severe Plaque Psoriasis Status COMPLETED Phase PHASE3
NCT01970475 Efficacy and Safety Study of ABP 501 Compared to Adalimumab in Subjects With Moderate to Severe Rheumatoid Arthritis Status COMPLETED Phase PHASE3
NCT01967160 Osteonecrosis of the Jaw (ONJ) and Infection Among Nordic Cancer Patients Treated With XGEVA™ or Zoledronic Acid Status COMPLETED Phase N/A
NCT01966003 Efficacy and Safety Study of ABP 215 Compared With Bevacizumab in Patients With Advanced Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE3
NCT01959698 Carfilzomib, Rituximab, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Relapsed or Refractory Stage I-IV Diffuse Large B-cell Lymphoma Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT01953341 Single-Ascending Dose Study of AMG 333 in Healthy Subjects and Subjects With Migraines Status COMPLETED Phase PHASE1
NCT01953328 Study of Low-Density Lipoprotein Cholesterol (LDL-C) Reduction Using Evolocumab (AMG 145) in Japanese Patients With Advanced Cardiovascular Risk Status COMPLETED Phase PHASE3
NCT01952574 Study to Evaluate the Efficacy and Safety of Erenumab (AMG 334) in Migraine Prevention Status COMPLETED Phase PHASE2